Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
The European Commission will put forward a legislative proposal next week that could give banks more room for flexibility when applying the IFRS 9 accounting standards. -
The coronavirus pandemic is shaking up the competitive landscape in capital markets, as some firms find it harder to commit to deals — but there are winners, too, and one of the most notable cases is BNP Paribas’s presence in the syndicated loan market.
-
The Covid-19 coronavirus is complicating the Libor transition and could even damage the risk profile of CME Group and LCH, Fitch Ratings has warned.
-
After years of being in the shade of their high yield colleagues, equity-linked bankers are emerging from the Covid-19 global pandemic as some of the biggest fee earners in the capital markets amid an issuance boom, particularly in the US, as embattled corporates scramble to raise liquidity.
-
The European Council announced little in the way of progress following its meeting on Thursday night, but spreads for bonds from the eurozone periphery proved more resilient than they did following the Eurogroup’s meeting two weeks ago.
-
Dufry, the Swiss duty free concession operator, attracted healthy demand for its emergency sale of new shares and convertible bonds on Thursday night — a transaction designed to raise as much liquidity as possible so it can survive the coronavirus pandemic, which has led to a huge drop in the number of shoppers at its airport stores.
